医药生物行业周报:关注一次性手套行业投资机会-20260322
Bank of China Securities·2026-03-22 12:16

Investment Rating - The industry investment rating is "Outperform the Market" [2][45]. Core Insights - The Shenyin Wanguo Pharmaceutical Bio Index fell by 3.21% from March 16 to March 20, 2026, ranking 10th among the first-level industries and underperforming the CSI 300 Index by 0.97 percentage points. Only the traditional Chinese medicine and biological products sectors outperformed the CSI 300 Index during this period [2][3]. - Due to geopolitical conflicts, international oil prices have been fluctuating upwards, leading to rising prices for core raw materials such as butadiene and acrylonitrile, which are essential for the disposable glove industry. This has initiated a price increase cycle in the disposable glove sector, likely boosting profits for leading companies [2][27][30]. Summary by Sections Industry Performance - The Shenyin Wanguo Pharmaceutical Bio Index's TTM price-to-earnings ratio is 47.95, which is still lower than the high valuation levels seen in 2021 [3][18]. - All sub-sectors within the pharmaceutical and biological industry experienced declines, with only traditional Chinese medicine and biological products showing relative strength against the CSI 300 Index [12][13]. Investment Recommendations - Focus on sectors with stable growth, such as medical devices and pharmaceuticals, which have stabilized competition. Recommended companies include: - Orthopedics: Sanyou Medical, Dabo Medical, Aikang Medical, Weigao Orthopedics - Ophthalmology: Aibo Medical - Cardiovascular: Huitai Medical, Xinmai Medical, Lepu Medical - In the innovative drug sector, recommended companies include: Innovent Biologics, Kintor Pharmaceutical, Kelun Pharmaceutical, Bai Li Tianheng, Betta Pharmaceuticals, Maiwei Biologics, and Nocankang [5]. - In the medical services sector, recommended companies include: Aier Eye Hospital, Tongce Medical, Haijia Medical, and Samsung Medical [5]. Key Industry News - The disposable glove industry is expected to enter a price increase cycle due to rising raw material costs, which account for a significant portion of production costs. For instance, raw materials constitute approximately 39% of the total cost for leading glove manufacturer Top Glove [30][27]. - Recent reports indicate that the prices of key raw materials like butadiene and acrylonitrile have risen significantly, with the price of acrylonitrile in the East China market increasing by 2.8% recently [29][30].

医药生物行业周报:关注一次性手套行业投资机会-20260322 - Reportify